#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting

#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting

Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online

La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h

#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online

#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting

Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:

#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLconnect: The TGF-β pathway: A pharmacological target in hepatocellular carcinoma?

Isabel Fabregat

Bellvitge Biomedical Research Institute (IDIBELL), Spain
Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBERehd), Spain
University of Barcelona (UB), Spain

15/01/2021 13:00-14:00

Microsoft Teams Meeting

Webinar IRISCAT-Dr. Rafael Máñez “Generació d’immunitat protectora contra les infeccions”

Rafael Máñez Mendiluce

Cap del grup Immunitat innata i patologia del malalt crític de l’IDIBELL.
Cap del Servei de Medicina Intensiva. Hospital Universitari de Bellvitge.

20/01/2021 16:00-


#IDIBELLconnect: Modeling cellular plasticity to regenerate the intestine

Jordi Guiu

Bellvitge Biomedical Research Institute (IDIBELL), Spain
Program for Clinical Translation of Regenerative Medicine of Catalonia (P-CMR[C])

29/01/2021 13:00-14:00

Microsoft Teams Meeting

#IDIBELLseminars: Genome engineering technologies applied to standardisation

The National Institute for Biological Standards and Control (NIBSC, an agency of the Department of Health and…

Read More

Heterogeneity, cross-talks and origin of pancreatic cancer: Insights from the transcriptome and methylome of purified cell populations

Desmoplasia is a hallmark of pancreatic ductal adenocarcinoma (PDAC), still one of the most deadly cancer types….

Read More

#IDIBELLfellows: Mariona Chicón / Sergi Fernández

 Deciphering the metastatic process of Ewing sarcoma Mariona Chicón Sarcoma Group       Oncological outcomes of…

Read More

#IDIBELLfellows: Carolina Martínez Herráez / Cristina Moreta

Anabolic storage in ribosome biogenesis addicted cancer: The 40S-LARP1 complex Carolina Martínez Herráez Metabolism and Cancer Group…

Read More

#IDIBELLseminars: Coffee and depression: A new window to grasp the neurobiology of depression?

Depressive-like conditions are the most frequent neuropsychiatric disorders and represent the major socio-economical burden in Western countries….

Read More

#IDIBELLseminars: Animal models for human liver cancer: From pathogenesis to therapy

Primary liver cancer (PLC) ranks among the most frequent and deadly tumor entities worldwide. PLC consists mainly…

Read More

#IDIBELLseminars: Tumor cell-intrinsic and -extrinsic roles of the integrated stress response in malignant progression and metastasis

Constantinos Koumenis Perelman School of Medicine, University of Pennsylvania, PA, USA Tumor progression and metastasis is associated…

Read More

Políticas de género en las instituciones científicas

Experiencias de institucionalización de la perspectiva de género en centros de investigación científica. Con la colaboración de…

Read More

#IDIBELLseminars: Defining epithelial changes in early-life gut development and immunity to infection

Menno Oudhoof Centre for Molecular Inflammation Research (CEMIR) Epithelium is fundamental for our health and wellbeing. Its…

Read More

#IDIBELLseminars: Inhibition of the sulfatase of steroid hormones improves aging and symptoms of Alzheimer’s disease in nematode and mice models

Manuel Muñoz Centro Andaluz de Biología del Desarrollo – Pablo Olavide University Steroid hormones can be modified…

Read More
Scroll to Top